company background image
AFT logo

AFT Pharmaceuticals Informe acción NZSE:AFT

Último precio

NZ$2.65

Capitalización de mercado

NZ$274.7m

7D

6.9%

1Y

-20.9%

Actualizada

21 Nov, 2024

Datos

Finanzas de la empresa +

AFT Pharmaceuticals Limited

Informe acción NZSE:AFT

Capitalización de mercado: NZ$274.7m

Resumen de acción AFT

AFT Pharmaceuticals Limited, junto con sus filiales, se dedica al desarrollo y venta de productos farmacéuticos en Nueva Zelanda, Australia, Asia e internacionalmente. Saber más

Análisis fundamental de AFT
Puntuación del snowflake
Valoración3/6
Crecimiento futuro2/6
Rendimiento pasado5/6
Salud financiera6/6
Dividendos0/6

Recompensas

Análisis de riesgos

No se han detectado riesgos en AFT a partir de nuestros controles de riesgos.

Competidores de AFT Pharmaceuticals Limited

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de AFT Pharmaceuticals
Precios históricos de las acciones
Precio actual de la acciónNZ$2.65
Máximo en las últimas 52 semanasNZ$3.85
Mínimo de 52 semanasNZ$2.37
Beta0.37
1Cambio en 1 mes-20.18%
Variación en 3 meses-18.71%
Cambio de 1 año-20.90%
3Variación en 3 años-45.25%
Variación en 5 años-15.06%
Variación desde la OPV-14.52%

Noticias y actualizaciones recientes

AFT Pharmaceuticals Limited (NZSE:AFT) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Nov 17
AFT Pharmaceuticals Limited (NZSE:AFT) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year

Jul 26
It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year

Recent updates

AFT Pharmaceuticals Limited (NZSE:AFT) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Nov 17
AFT Pharmaceuticals Limited (NZSE:AFT) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year

Jul 26
It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year

AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

May 25
AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?

May 22
Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?

Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?

Oct 17
Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?

Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?

May 23
Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?

Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?

Dec 01
Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?

We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise

Jul 30
We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise

With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For

Jun 02
With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For

Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?

Mar 20
Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?

A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation

Feb 13
A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation

Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 23
Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?

Jan 02
Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?

Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?

Dec 12
Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?

AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 21
AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Rentabilidad de los accionistas

AFTNZ PharmaceuticalsMercado NZ
7D6.9%-11.4%0.1%
1Y-20.9%34.7%9.6%

Rentabilidad vs. Industria: Los resultados de AFT fueron inferiores a los de la industria NZ Pharmaceuticals, que obtuvo un rendimiento del 34.7% el año pasado.

Rentabilidad vs. Mercado: AFT obtuvo unos resultados inferiores a los del mercado NZ, que fueron del 9.6% el año pasado.

Volatilidad de los precios

Is AFT's price volatile compared to industry and market?
AFT volatility
AFT Average Weekly Movement4.8%
Pharmaceuticals Industry Average Movement11.9%
Market Average Movement4.5%
10% most volatile stocks in NZ Market9.3%
10% least volatile stocks in NZ Market3.0%

Precio estable de las acciones: AFT no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de AFT (5%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
1997110Hartley Atkinsonwww.aftpharm.com

AFT Pharmaceuticals Limited, junto con sus filiales, se dedica al desarrollo y venta de productos farmacéuticos en Nueva Zelanda, Australia, Asia e internacionalmente. Ofrece productos para alergias, gastrointestinales, gripe y resfriados, salud digestiva, oftalmología, primeros auxilios, cuidado de las uñas, cuidado bucal, tratamiento del dolor, cuidado de la piel, vitaminas y suplementos, así como otros productos. AFT Pharmaceuticals Limited se constituyó en 1997 y tiene su sede en Auckland (Nueva Zelanda).

Resumen de fundamentos de AFT Pharmaceuticals Limited

¿Cómo se comparan los beneficios e ingresos de AFT Pharmaceuticals con su capitalización de mercado?
Estadísticas fundamentales de AFT
Capitalización bursátilNZ$274.75m
Beneficios(TTM)NZ$15.61m
Ingresos (TTM)NZ$195.41m

17.8x

Ratio precio-beneficio (PE)

1.4x

Ratio precio-ventas (PS)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de AFT
IngresosNZ$195.41m
Coste de los ingresosNZ$107.14m
Beneficio brutoNZ$88.27m
Otros gastosNZ$72.66m
BeneficiosNZ$15.61m

Últimos beneficios comunicados

Mar 31, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)0.15
Margen bruto45.17%
Margen de beneficio neto7.99%
Ratio deuda/patrimonio32.1%

¿Cómo se ha desempeñado AFT a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

0.6%

Rentabilidad actual por dividendo

11%

Ratio de pagos